Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma <i>In vitro</i> and <i>In vivo</i>

Nobuyuki Watanabe, Yoshio Naomoto(Okayama University)
Clinical Cancer Research
July 15, 2008
Cited by 52


Related Papers